Evaluating the Prognostic Impact of Apparent Diffusion Coefficient in Definitive Radiotherapy for Gleason Score 7 Prostate Cancer Patients
The Prostate · 2025
DOI: 10.1002/pros.24833 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Prostate, 2025. Verfasst von Cem Onal und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Baskent University Faculty of Medicine, Ankara, Turkey. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Diffusion Magnetic Resonance Imaging. Die Arbeit nennt 33 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
To investigate the utility of diffusion‐weighted magnetic resonance imaging (DW‐MRI) in evaluating Gleason score (GS) 7 tumors before definitive radiotherapy (RT) and to explore its association with clinicopathological factors and treatment outcomes. Materials and Methods Clinical data of 266 prostate cancer (PCa) patients with biopsy‐confirmed GS 7 who underwent RT were retrospectively analyzed. Pretreatment DW‐MRI was utilized to measure apparent diffusion coefficient (ADC) values of primary tumors. Treatment outcomes, including biochemical disease‐free survival (bDFS) and prostate cancer‐specific survival (PCSS), were assessed. Statistical analyses were conducted to determine the correlation between tumor ADC values, clinicopathological factors, and treatment outcomes.
Results
Tumors with a GS of 3 + 4 had significantly higher ADC values than those with a GS of 4 + 3 (0.746 ± 0.150 vs. 0.702 ± 0.157 × 10 − ³ mm²/s; p < 0.001). Median follow‐up time was 8.6 years, and the 7‐year rates for bDFS and PCSS were 89.1% and 95.3%, respectively. Lower tumor ADC values were significantly correlated with higher GS and increased risk of disease progression. A primary tumor ADC cutoff value of 0.682 × 10 − ³ mm²/s was identified for predicting disease progression. Patients with higher ADC values exhibited significantly better 7‐year bDFS rates (92.8% vs. 83.2%; p = 0.02). However, GS 4 + 3 tumors independently predicted poorer bDFS and PCSS outcomes. In the multivariable analysis, only GS 4 + 3 tumor was predictive for worse bDFS and PCSS.
Conclusions
Tumor ADC values are a reliable biomarker for differentiating between GS 3 + 4 and 4 + 3 tumors in the GS 7 category. Tumors exhibiting lower ADC values have been associated to higher risk factors and an increased likelihood of disease progression, particularly in GS 3 + 4 tumors where GS upgrading could happen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Baskent University Faculty of Medicine, Ankara, Turkey.
- Department of Radiation Oncology, Baskent University Faculty of Medicine Adana Dr. Turgut Noyan Research and Treatment Center, Adana, Turkey.
- Department of Radiology, Baskent University Faculty of Medicine Adana Dr. Turgut Noyan Research and Treatment Center, Adana, Turkey.
- Division of Radiation Oncology, Iskenderun Gelisim Hospital, Hatay, Turkey.
- Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
ORCID-Profile: Cem Onal, Aysenur Elmali, Birhan Demirhan
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Onal, C., Elmali, A., Erbay, G., Demirhan, B., Sutera, P., Deek, M. P., Tran, P. T., & Guler, O. C. (2025). Evaluating the Prognostic Impact of Apparent Diffusion Coefficient in Definitive Radiotherapy for Gleason Score 7 Prostate Cancer Patients. The Prostate. https://doi.org/10.1002/pros.24833
Vancouver
Onal C, Elmali A, Erbay G, Demirhan B, Sutera P, Deek MP, et al. Evaluating the Prognostic Impact of Apparent Diffusion Coefficient in Definitive Radiotherapy for Gleason Score 7 Prostate Cancer Patients. The Prostate. 2025. doi:10.1002/pros.24833
BibTeX
@article{Onal2025,
author = {Onal, Cem and Elmali, Aysenur and Erbay, Gurcan and Demirhan, Birhan and Sutera, Philip and Deek, Matthew P and Tran, Phuoc T and Guler, Ozan Cem},
title = {Evaluating the Prognostic Impact of Apparent Diffusion Coefficient in Definitive Radiotherapy for Gleason Score 7 Prostate Cancer Patients},
journal = {The Prostate},
year = {2025},
doi = {10.1002/pros.24833}
}
EUVIMED